A Drug-Drug Interaction Study of Carbamazepine and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-012)
Clinical trial NCT06633419 · COMPLETED
Trial details
- NCT number
- NCT06633419
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-18
- Primary completion
- 2025-02-12
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.